Results 1 to 10 of about 5,734,181 (299)

Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome. [PDF]

open access: yesEFSA J, 2023
Development of adverse outcome pathways (AOPs) for uterine adenocarcinoma can provide a practical tool to implement the EFSA‐ECHA Guidance (2018) for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No ...
EFSA Panel on Plant Protection Products and their Residues (PPR)   +26 more
europepmc   +4 more sources

An integrative systems biology strategy to support the development of adverse outcome pathways (AOPs): a case study on radiation-induced microcephaly. [PDF]

open access: yesFront Cell Dev Biol, 2023
Adverse Outcome Pathways (AOPs) are useful tools for assessing the potential risks associated with exposure to various stressors, including chemicals and environmental contaminants.
Jaylet T   +3 more
europepmc   +4 more sources

Micro- and Nano-Plastics Activation of Oxidative and Inflammatory Adverse Outcome Pathways

open access: yesRedox Biology, 2020
Microplastics (MPs) and nanoplastics (NPs) have attracted considerable attention in the recent years as potential threats to the ecosystem and public health.
Dusan Palic
exaly   +4 more sources

Adverse Outcome Pathways: A Concise Introduction for Toxicologists [PDF]

open access: yesArchives of Toxicology, 2017
Adverse outcome pathways (AOPs) are designed to provide a clear-cut mechanistic representation of critical toxicological effects that propagate over different layers of biological organization from the initial interaction of a chemical with a molecular target to an adverse outcome at the individual or population level.
Mathieu Vinken   +2 more
exaly   +6 more sources

Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways. [PDF]

open access: yesJ Clin Med, 2022
Alteration in gut microbiota has been associated with COVID-19. However, the underlying mechanisms remain poorly understood. Here, we outlined three potential interconnected mechanistic pathways leading to gut dysbiosis as an adverse outcome following ...
Clerbaux LA   +6 more
europepmc   +4 more sources

Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study. [PDF]

open access: yesInt J Mol Sci
The evolving landscape of chemical risk assessment is increasingly focused on developing tiered, mechanistically driven approaches that avoid the use of animal experiments.
Ortega-Vallbona R   +6 more
europepmc   +3 more sources

Natural language processing in toxicology: Delineating adverse outcome pathways and guiding the application of new approach methodologies. [PDF]

open access: yesBiomater Biosyst, 2022
Highlights • Natural language processing can support adverse outcome pathways building.• Natural language processing can support new approach methodologies development.
Corradi MPF   +7 more
europepmc   +4 more sources

Exploring genetic influences on adverse outcome pathways using heuristic simulation and graph data science. [PDF]

open access: yesComput Toxicol, 2023
Adverse outcome pathways provide a powerful tool for understanding the biological signaling cascades that lead to disease outcomes following toxicity.
Romano JD   +4 more
europepmc   +2 more sources

Semantic characterization of adverse outcome pathways. [PDF]

open access: yesAquat Toxicol, 2020
This study was undertaken to systematically assess the utilities and performance of ontology-based semantic analysis in adverse outcome pathway (AOP) research. With an increasing number of AOPs developed by scientific domain experts to organize toxicity information and facilitate chemical risk assessment, there is a pressing need for objective ...
Wang RL.
europepmc   +4 more sources

Integration of Adverse Outcome Pathways, Causal Networks and 'Omics to Support Chemical Hazard Assessment. [PDF]

open access: yesFront Toxicol, 2022
Several approaches have been used in an attempt to simplify and codify the events that lead to adverse effects of chemicals including systems biology, ‘omics, in vitro assays and frameworks such as the Adverse Outcome Pathway (AOP).
Perkins EJ, Woolard EA, Garcia-Reyero N.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy